Viridescent Capital Partners is a global investment management firm focused on making scalable, diversified investments in the cannabis industry.

Viridescent Capital Partners

Viridescent Capital Partners LP | 416 followers on LinkedIn. Viridescent Capital Partners is a private equity firm that brings extensive experience and flexible capital solutions to companies across the cannabis industry. 
 
Our executive team brings more than 60 years of combined capital markets experience and more than 20 years of operating and investing experience in the cannabis industry, making us a credible partner for investors looking to access the cannabis space. 
 
Our deep domain experience and understanding in cannabis make us a powerful ally for companies seeking a partner to foster growth and help facilitate company success through an extensive network that spans the cannabis value chain.

Founder & Chief Investment Officer at Viridescent Capital Partners LP

Kevin Murphy

Strategic Advisor for Viridescent Capital Partners LP

Drew Dawson

Head of Origination and Partner at Viridescent Capital Partners LP

Dennis Byrne

Chief Operating Officer and Partner at Viridescent Capital Partners LP

Dante Domenichelli

Viridescent Capital Partners LP

https://lnkd.in/gQbu_f5e The U.S. government recently proposed rescheduling cannabis from a Schedule I to a Schedule III drug — basically signaling it has some accepted medical use and a moderate to low potential for physical and psychological dependence. But what does this mean in the real world exactly? Sanjay talks with “The Pot Doc” Dr. Staci Gruber, Director of the Marijuana Investigations for Neuroscientific Discovery (MIND) program in Boston, to explore the possible impacts of this rescheduling on research, healthcare, and yes – even you.

VIRI

COM:VIRIDESCENTCAPITAL

Viridescent Capital Partners